DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Docmode Health Technologies Limited — Outcome of Board Meeting

NSE 1 hr ago·4 Sept 2026, 2:24 pm

Docmode Health Tech

Docmode Health Technologies Limited has informed the stock exchange about its financial results for the period ending March 31, 2026. This announcement follows the conclusion of the company's board meeting and marks a key update for the company's public disclosures.

For investors, this update is significant as it provides the latest financial performance data. This information is essential for assessing the company's current health, operational efficiency, and overall trajectory in the market.

Investors should closely monitor the specific details of the results, including revenue growth, profitability, and cash flow. These figures will be crucial in determining the company's future strategy and its potential impact on the stock price.